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Abstract
Background Post-thyroidectomy hypocalcemia is a major
contributing factor in delayed hospital discharge and dis-
suading surgeons from ambulatory thyroidectomy. We
prospectively evaluated the accuracy and reliability of
quick parathyroid hormone level measurement at skin
closure (PTH-SC) in predicting clinically relevant hypo-
calcemia (i.e., patients requiring calcium ± calcitriol sup-
plements on hospital discharge).
Methods Of the 117 patients who underwent a total or
completion total thyroidectomy and PTH-SC, 17 (14.5 %)
had hypocalcemic symptoms or adjusted calcium \1.90
mmol/L requiring calcium and/or calcitriol supplements on
discharge. Serum calcium was checked regularly in the
perioperative period until stabilization and an additional
quick PTH was checked on the following morning (PTH-
D1). Univariate and multivariate analyses were performed
to evaluate potential preoperative clinicopathologic factors
and postoperative day 0 biochemical indicators. Youden’s
index and the area under the ROC curve (AUC) were used
to determine the best cutoff value and predictability of
signiﬁcant variables or criteria, respectively.
Results In the multivariate analysis, low preoperative
adjusted calcium (p = 0.041) and low PTH-SC (p = 0.001)
were the two independent variables associated with hypo-
calcemia. PTH-SC (B1o r[1 pmol/L) had a higher speci-
ﬁcity (95.0 %) and AUC (0.887) than serial calcium
monitoring or PTH-D1 alone. Although 3/98 of patients with
PTH-SC [1 pmol/L required calcium supplements on dis-
charge, they required only the minimum amount to maintain
normocalcemia.
Conclusion PTH-SC is an accurate and reliable means of
predicting clinically relevant hypocalcemia. It would be
reasonable to discharge those with PTH-SC[1 pmol/L on
the same operative day as the risk of life-threatening
hypocalcemia would seem unlikely.
Introduction
Postoperative transient hypoparathyroidism leading to hypo-
calcemia is the one of the most frequent morbidities fol-
lowing total thyroidectomy, with incidence ranging between
3 and 40 % [1, 2]. In addition, because potentially life-
threatening hypocalcemia may not develop until 24–48 h
after surgery, besides postoperative bleeding and hematoma
formation, hypoparathyroidism is a major reason for delayed
hospital discharge and dissuading surgeons from performing
ambulatory thyroid surgery [3, 4]. To safely manage post-
operative hypoparathyroidism/hypocalcemia, three approa-
ches had been described, namely, serial calcium (Ca)
monitoring [5, 6], routine Ca supplementation [7, 8], and
parathyroid hormone (PTH)-directed supplementation [9].
Serial Ca monitoring is often adopted because Ca testing is
widely available but involves patients staying for at least 1–2
nights in hospital [2, 5, 6]. In the era of cost containment,
there has been a gradual shift from serial Ca monitoring to
the other two approaches [7–9]. Our group previously
reported that a \75 % decline in quick PTH level from
preoperative to 10-min post excision could accurately iden-
tify normocalcemic patients [10]. However, this approach
required the collection of several samples during surgery and
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erative PTH level [11, 12]. As a result, some authors have
advocated the use of a single PTH test some time after sur-
gery [9–13]. To date, numerous PTH criteria have been
proposed but none have clearly been shown to be superior
[9, 12, 13]. Recent reviews suggested that a single PTH
measurement taken any time from 10 min to several hours
postoperatively seemed to provide equally accurate predic-
tive results [12, 13]. In our clinical setting, a single quick
PTH level measurement taken at the time of skin closure
(PTH-SC) while the patient is still anesthetized would be
preferred because no extra pain is inﬂicted while drawing
blood and the PTH result would be available sooner to
facilitate ambulatory surgery. Therefore, the aim of our study
was to evaluate prospectively the accuracy and reliability of
quick PTH-SC in predicting clinically relevant postoperative
hypocalcemia. The study ﬁrst analyzed potential risk factors
and biochemical indicators associated with hypocalcemia and
then compared the sensitivity, speciﬁcity, and predictability
of PTH-SC with other biochemical variables or criteria such
as serial Ca monitoring and following-morning PTH level
(PTH-D1).
Patients and methods
This was a prospective study carried out from January to
June 2011 that included all patients who underwent either a
total or a completion total thyroidectomy for benign or
malignant disease. All patients were operated on and cared
for by the same surgical team. The present study protocol
was approved by the local institutional review board. The
quick PTH level measurements were taken immediately
at the time of skin closure (PTH-SC) (approximately
5–10 min after thyroid gland removal) while the
patient was still anesthetized, and the following morning
(approximately 24 h after operation) on postoperative day
1 (PTH-D1). Serum Ca and phosphate levels were checked
preoperatively, within 1 h after surgery, the following
morning, and every 8–10 h until stabilization. There were
125 consecutive patients who underwent total or comple-
tion total thyroidectomy over the study period. Those with
concomitant selective neck dissection (n = 4) and incom-
plete PTH values (n = 4) were excluded leaving 117
(93.6 %) whose data were eligible for analysis. For this
study, only those with hypocalcemic symptoms and/or a
serum Ca\1.90 mmol/L (normal range = 2.11–2.55 mmol/L)
(i.e., clinically relevant hypocalcemia) were given
500–1,500-mg calcium tablets daily. Calcitriol 0.25 mcg
twice daily was added if the 1,500-mg calcium tablets
alone failed to maintain normocalcemia. To avoid treat-
ment bias, the result of the quick PTH-SC was not made
available to the person responsible for prescribing
supplements. On hospital discharge, there were 100
(85.5 %) patients who did not require any oral calcium ±
calcitriol (group I), while 17 (14.5 %) required some sup-
plements (group II). To analyze possible risk factors or
predictors for hypocalcemia, patients’ clinicopathological
data and postoperative day 0 biochemical indicators of the
patients in the two groups were compared.
Surgical techniques, postoperative care, and follow-up
protocol had been previously described [2, 14]. Thyroid-
ectomy was performed in a standardized manner under
general anesthesia. The strap muscles were separated in the
midline and retracted laterally. Both recurrent laryngeal
nerves and parathyroid glands were routinely identiﬁed and
preserved. Any devascularized parathyroid glands were
immediately minced and autoimplanted to the ipsilateral
sternocleidomastoid muscle. A wound drain was not used.
Operative ﬁndings such as the weight of the excised
thyroid gland and the number of parathyroid glands iden-
tiﬁed and autotransplanted were recorded. Oral thyroxin
supplement was given on discharge. All postsurgical
patients were followed up within 1 week and were asked
speciﬁcally about hypocalcemic symptoms after hospital
discharge. They were then followed up every 2–3 months
for the ﬁrst year. Those taking calcium ± calcitriol sup-
plements were followed more frequently with the aim of
slowly weaning the patient off these supplements while
maintaining normocalcemia. By deﬁnition, those who dis-
continued all supplements in the presence of normocalcemia
within 6 months of surgery were regarded as having tem-
porary hypoparathyroidism, whereas those who continued
on the supplements for more than 6 months were catego-
rized as having permanent hypoparathyroidism.
Laboratory methods
Serum albumin-adjusted Ca and phosphate levels were
measured in the hospital laboratory by standard methods
using the Roche Diagnostics Modular Analytic System
(Roche Diagnostics, Indianapolis, IN, USA). Quick PTH
level was measured by the Access
 2 immunoassay system
(Beckman Coulter, Brea, CA, USA), and the inter- and
intra-assay CVs were 5.8 and 4.5 %, respectively. The
normal range for serum PTH level was 1.2–5.7 pmol/L.
Statistics
For comparison of dichotomous variables between the two
groups, v
2 test and Fisher’s exact test were used. The
Mann–Whitney U test was used for comparison of con-
tinuous variables. Any preoperative and postoperative day
0 biochemical variables that were signiﬁcant in the
univariate analysis were entered into multivariate analysis
to determine independent factors. To improve clinical
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was used to calculate the best cutoff value for predicting
hypocalcemia [15]. The area under a receiver characteristic
(ROC) curve (AUC) was used to measure the relative
predictability of these variables or criteria. AUC values
close to 1.00 meant better predictability and those close
to 0.500 meant poorer predictability. All statistical analy-
ses were conducted using SPSS ver. 18.0 (SPSS, Inc.,
Chicago, IL, USA). p\0.05 was considered statistically
signiﬁcant.
Results
The median age of our cohort of 117 patients was 50.0
(range = 16.1–84.2) and the male:female ratio was 1:8.8.
One-hundred nine patients (93.2 %) underwent a total
thyroidectomy while 8 (6.8 %) had a completion total
thyroidectomy. The median hospital stay was 2 (range = 2–5)
days. Of the 17 patients who required supplements on dis-
charge, 11 required calcium tablets alone while 6 required
both calcium and calcitriol supplements. On follow-up, no
patient experienced unexpected hypocalcemic symptoms or
required readmission. After a median follow-up of 6.2
(range = 3.6–9.4) months, 15 of 17 (88.2 %) patients were
successfully taken off supplements while 2 patients contin-
ued to take calcium and calcitriol. Since these two (1.7 %)
patients took supplements for[6 months, they were regar-
ded as having permanent hypoparathyroidism.
Table 1 compares patient baseline characteristics, surgi-
cal indication, and operative ﬁndings between group I and
group II. Median age and sex ratio were similar between the
two groups. Group II had a higher proportion of Graves’/
toxic multinodular goiter (MNG) (29.4 vs. 10.0 %, p =
0.043) and a lower proportion of benign thyroid pathology
than group I (52.9 vs. 80.0 %, p = 0.028). The overall rates
of postoperative hypocalcemia in patients with malignancy,
Graves’/toxic MNG, and benign pathology were 30.0, 33.3,
and 10.1 %, respectively. The incidence of concomitant
autoimmune thyroiditis, operative blood loss, and the weight
of the excised thyroid gland were similar between the two
groups, but the duration of the operation was signiﬁcantly
longer in group II, perhaps reﬂecting the difﬁculty of the
procedure. Group II had a signiﬁcantly greater number of
parathyroid glands identiﬁed (p = 0.017) and a greater
number of parathyroid glands autotransplanted (p = 0.019)
than group I.
Table 2 compares preoperative thyroid function, thyroid
auto-antibodies, and the perioperative biochemical proﬁle
between groups I and II. Preoperative TSH level and
antithyroid auto-antibodies titer were similar between the
two groups. Relative to group I, group II had signiﬁcantly
lower preoperative adjusted Ca (2.22 vs. 2.29 mmol/L,
p\0.001), postoperative 1-h adjusted Ca (2.10 vs.
Table 1 Comparison of patient
baseline characteristics, surgical
indication, and operative
ﬁndings between those with
normocalcemia (i.e., no signs of
hypocalcemia and adjusted
calcium C1.90 mmol/L)
(group I) and those with
hypocalcemia (i.e., with either
hypocalcemic symptoms
and/or adjusted calcium
\1.90 mmol/L) (group II) after
bilateral thyroid resection
Bold values indicate statistically
signiﬁcant at p-values\0.05
MNG multinodular goiter
Variable Group I (n = 100) Group II (n = 17) p value
Age at operation (years) 51.2 (17.9–84.3) 45.0 (15.8–68.4) 0.124
Gender (male:female) 11:89 1:16 1.000
Surgical indication/ﬁnal pathology
Malignancy 10 (10.0) 3 (17.6) 0.400
Graves’ disease/toxic MNG 10 (10.0) 5 (29.4) 0.043
Benign pathology 80 (80.0) 9 (52.9) 0.028
Concomitant autoimmune thyroiditis 10 (10.0) 2 (11.8) 0.686
Duration of operation (min) 56.5 (41–175) 72.5 (39–155) 0.012
Blood loss (mL) 10 (10–200) 10 (10–30) 0.080
Weight of excised gland (g) 30 (7–225) 38 (18–73) 0.083
No. of parathyroid glands identiﬁed 0.017
None 14 (14.0) 0 (0.0)
1 6 (6.0) 1 (5.9)
2 27 (27.0) 0 (0.0)
3 2 (2.0) 3 (17.6)
4 51 (51.0) 13 (76.5)
No. of parathyroid glands auto-transplanted 0.019
None 84 (84.0) 10 (58.8)
1 13 (13.0) 6 (35.3)
2 3 (3.0) 1 (5.9)
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1232.18 mmol/L, p\0.001), and postoperative 16-h adjusted
Ca (1.94 vs. 2.19 mmol/L, p\0.001). In terms of PTH
levels, group II had signiﬁcantly lower PTH-SC (3.3 vs.
3.7, p\0.001) and PTH-D1 (0.1 vs. 0.6, p\0.001) than
group I. Overall, the PTH-SC level was signiﬁcantly lower
than PTH-D1 (p\0.001).
Table 3 gives a multivariable analysis of clinicopatho-
logical risk factors and postoperative day 0 biochemical
indicators for postoperative hypocalcemia requiring cal-
cium ± calcitriol supplementation after surgery. For post-
operative day 0 biochemical indicators, only postoperative
1-h adjusted Ca and PTH-SC were considered. After
adjusting for other signiﬁcant factors, low preoperative
adjusted Ca [ß coefﬁcient =- 17.7, odds ratio = 0.001
(95 % CI: 0.001–0.502), p = 0.041] and low PTH-SC
[ß coefﬁcient = 2.063, odds ratio = 7.872 (95 % CI:
2.239–27.669), p = 0.001] were the two independent
variables associated with hypocalcemia.
Figure 1 shows the PTH-SC for groups I and II after
surgery.
Table 4 compares test sensitivity, speciﬁcity, and pre-
dictability as measured by area under the receiver operating
Table 2 Comparison of preoperative thyroid function, thyroid auto-
antibodies, and perioperative biochemical proﬁle between those with
normocalcemia (i.e., no signs of hypocalcemia and adjusted calcium
C1.90 mmol/L) (group I) and those with hypocalcemia (i.e., with
either hypocalcemic symptoms and/or adjusted calcium\1.90 mmol/
L) (group II) after bilateral thyroid resection
Variable Group I (n = 100) Group II (n = 17) p
Preoperative TSH level (mIU/L) 0.81 (0.03–2.80) 0.87 (0.04–2.20) 0.781
Antithyroglobulin antibody (titer) 0.130
\100 70 (70.0) 12 (70.6)
100–400 15 (15.0) 0
400 5 (5.0) 5 (29.4)
Antimicrosomal antibody (titer) 0.130
\100 70 (70.0) 12 (70.6)
100–400 15 (15.0) 0 (0.0)
[400 5 (5.0) 5 (29.4)
Preoperative adjusted calcium (mmol/L) 2.29 (2.14–2.50) 2.22 (2.16–2.33) <0.001
Postoperative 1-h adjusted serum calcium (mmol/L) 2.18 (1.97–2.37) 2.10 (1.99–2.24) <0.001
Postoperative 24-h adjusted calcium (mmol/L) 2.19 (2.01–2.33) 1.94 (1.78–2.07) <0.001
Calcium drop from preoperative to postoperative 1 h (%) 4.74 (-1.82–16.00) 6.94 (1.36–10.76) 0.067
Calcium drop from postoperative 1–24 h (%) -0.46 (-9.50–7.11) 8.92 (-2.99–14.48) <0.001
Postoperative PTH at skin closure (PTH-SC) (pmol/L) 3.7 (0.3–16.3) 3.3 (0.1–18.0) <0.001
Postoperative PTH on postoperative day 1 (PTH-D1) (pmol/L) 0.6 (0.2–4.6) 0.1 (0.1–4.9) <0.001
Bold values indicate statistically signiﬁcant at p-values\0.05
TSH thyrotropin, PTH intact parathyroid hormone level
Table 3 Multivariable analysis
of clinicopathological risk
factors and postoperative day 0
biochemical indicators for
postoperative clinically relevant
hypocalcemia (i.e., either with
hypocalcemic symptoms and/or
adjusted calcium\1.90 mmol/
L) requiring calcium and/or
vitamin D supplementation after
surgery
Bold values indicate statistically
signiﬁcant at p-values\0.05
MNG multinodular goiter, PTH
intact parathyroid hormone, CI
conﬁdence interval
Covariates ß-coefﬁcient Odds ratio (95 % CI) p
Surgical indication
Malignancy 1 0.122
Graves’ disease/toxic MNG -0.476 0.622 (0.011–36.590) 0.819
Benign 2.482 11.959 (0.273–523.99) 0.198
Duration of operation (min) 0.001 1.001 (0.959–1.044) 0.981
No. of parathyroid glands seen
None 1 0.813
1–2 1.182 3.260 (0.031–345.683) 0.619
3–4 1.035 2.815 (0.102–78.018) 0.541
Parathyroid autotransplantation 0.004 1.004 (0.096–10.484) 0.817
Preoperative adjusted calcium (mmol/L) -17.672 0.001 (0.001–0.502) 0.041
Postoperative 1-h adjusted serum calcium (mmol/L) 1.448 4.254 (0.001–926591) 0.817
Postoperative PTH at skin closure (PTH-SC) (pmol/L) 2.063 7.872 (2.239–27.669) 0.001
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123characteristic curve (AUC) between serum Ca slopes, pre-
operative adjusted Ca, PTH-SC, PTH-D1, and a combined
preoperative Ca and PTH-SC score. In predicting hypocal-
cemia, the best cutoff values for PTH-SC and PTH-D1 were
B1.0 pmol/L (Youden’s index = 0.774; sensitivity 82.4 %
and speciﬁcity 95.0 %) and B0.6 pmol/L (Youden’s index =
0.695; sensitivity 76.5 % and speciﬁcity 93.0 %),
respectively. Interestingly, the test sensitivity, speciﬁcity, and
AUC were exactly identical between PTH-SC B1o r
[1 pmol/L and combined score B-1.4/[ -1.4, implying
that adding preoperative adjusted Ca to PTH-SC did not
improve the sensitivity, speciﬁcity, and predictability.
Table 5 compares PTH-SC B1o r[1 pmol/L between
groups I and II. Of the 17 patients in group II, 14 had PTH-
SC B1 pmol/L and 3 had PTH-SC [1 pmol/L. The three
patients with PTH-SC[1 pmol/L (1.9, 2.5, and 4.6 pmol/L)
required oral calcium supplements (1,000, 1,000, and
500 mg daily, respectively) alone, whereas 6 of the 14
patients with PTH-SC B1 pmol/L required both calcium
and calcitriol supplements to maintain normocalcemia on
discharge. Of these six patients, two suffered permanent
Fig. 1 The quick parathyroid hormone levels at the time of skin
closure (PTH-SC) in those with normocalcemia (i.e., no signs of
hypocalcemia and adjusted calcium C1.90 mmol/L) (group I) and
those with hypocalcemia (i.e., with either hypocalcemic symptoms
and/or adjusted calcium \1.90 mmol/L) (group II) after bilateral
thyroid resection
Table 4 Comparison of test sensitivity, speciﬁcity, and predictability
as measured by area under the receiver operating characteristic curve
(AUC) between serum calcium slopes, preoperative adjusted calcium,
parathyroid hormone (PTH) at skin closure (PTH-SC), PTH on
postoperative D1 (PTH-D1), and combined preoperative adjusted
calcium and PTH-SC score
Best cutoff value
b Test sensitivity
c
(%)
Test speciﬁcity
d
(%)
AUC (95 % CI)
Calcium drop from preoperative to
postoperative 1 h (%)
B5.7 70.6 65.0 0.674 (0.537–0.812)
[5.7
Calcium drop from postoperative 1 h to 24 h (%) B2.3 94.1 80.0 0.875 (0.793–0.956)
[2.3
Preoperative adjusted calcium (mmol/L) B2.27 58.0 76.5 0.670 (0.537–0.803)
[2.27
Postoperative PTH-SC (pmol/L) B1.0 82.4 95.0 0.887 (0.777–0.996)
[1.0
Postoperative PTH-D1(pmol/L) B0.6 76.5 93.0 0.847 (0.725–0.970)
[0.6
Combined preoperative adjusted calcium
and PTH-SC score
a
B-1.4 82.4 95.0 0.887 (0.777–0.996)
[-1.4
a Calculated from logistic regression. Combined score = 2.598–2.717 (Ca score) -5.301 (PTH score). For preoperative adjusted calcium
B2.27 mmol/L, Ca score was 1 and for PTH-SC B1.0 pmol/L, the PTH score was 1. For other values, the score would be 0
b Determined by the receiver operating characteristic curve and Youden’s index
c Sensitivity = true positives/(true positives ? false negatives)
d Speciﬁcity = true negatives/(true negatives ? false positives)
Table 5 Comparison of PTH value at the time of skin closure (PTH-
SC) B1o r[1 pmol/L between those with normocalcemia (i.e., no
signs of hypocalcemia and adjusted calcium C1.90 mmol/L) (group I)
and those with hypocalcemia (i.e., with either hypocalcemic symp-
toms and/or adjusted calcium\1.90 mmol/L) (group II) after bilateral
thyroid resection
Variable Group I
(n = 100)
Group II
(n = 17)
Total
number
PTH-SC B1 pmol/L 5 (FP) 14 (TP) 19
PTH-SC[1 pmol/L 95 (TN) 3 (FN) 98
Total number 100 17 117
FP false positive, TP true positive, TN true negative, FN false
negative
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123hypoparathyroidism and their PTH-SC values were 0.6 and
0.7 pmol/L, respectively. The PTH-SC level was not
signiﬁcantly different between those who eventually
developed temporary or permanent hypoparathyroidism
(p = 0.295).
Discussion
Transient hypoparathyroidism is a major reason for
delayed hospital discharge following a total or completion
total thyroidectomy because potentially life-threatening
hypocalcemic symptoms may not occur until 24–48 h after
surgery [3, 4]. Among the various strategies proposed to
optimize the management of postoperative hypocalcemia
by shortening hospital stay, PTH-directed selective sup-
plementation is a safe and effective approach [9, 10, 13].
However, many PTH criteria have been proposed by pre-
vious authors to predict which patients are at risk of
developing clinically relevant postoperative hypocalcemia
[9–13]. In general, these criteria can be categorized into
two main approaches, namely, focusing on the percentage
drop in PTH level from the preoperative to the postoper-
ative period or simply measuring a single postoperative
PTH level some time after surgery with a cutoff value
[9–13]. We chose the latter approach because there was no
need for drawing blood multiple times; this reduced the
clinical workload and the overall cost of PTH testing. In
regard to the timing, two evidence-based reviews suggested
a single PTH measurement taken any time from 10 min to
several hours after surgery seemed to provide equally
accurate predictive results [9, 13]. Barczynski et al. [12]
compared the accuracy between PTH-SC and PTH at 4 h
after surgery and found no signiﬁcant difference. With the
advantages of reduced pain, being logistically easier, and
the PTH results coming back sooner, the accuracy and
reliability of PTH-SC was evaluated.
In the ﬁrst part of analysis, preoperative clinicopatho-
logical risk factors and day 0 biochemical indicators
associated with hypocalcemia were evaluated in our cohort.
The reason for evaluating only day 0 biochemical indica-
tors (i.e., PTH-SC and not PTH-D1) was because we aimed
to assess any potential indicators or factors that might be
predictive in the setting of outpatient or ambulatory
thyroidectomy (i.e., patients being discharged on the same
day as surgery). Among the various signiﬁcant factors such
as Graves’/toxic MNG, duration of the operation, number
of parathyroid glands seen, parathyroid autotransplantation,
preoperative Ca, and PTH-SC, only the latter two turned
out to be independent factors associated with clinically
relevant hypocalcemia. To conﬁrm whether combining
these independent factors would further improve testing
accuracy, preoperative Ca was entered as a covariate with
PTH-SC in the logistic regression model and a formula for
hypocalcemia was generated (see Table 4). However, test
sensitivity, speciﬁcity, and AUC of this formula were
exactly identical to those of PTH-SC alone. Therefore, in
the ambulatory setting, PTH-SC B1/[1 pmol/L was
probably the single most accurate and most reliable test in
predicting clinically relevant hypocalcemia. Our analysis
also compared the accuracy of PTH-SC with that of con-
ventional serial Ca monitoring (or Ca slope) using their
best cutoffs and found that PTH-SC had higher speciﬁcity
and AUC than the two types of Ca slope, namely, from
preoperative to postoperative 1 h and from postoperative
1 h to 24 h. Therefore, PTH-SC might not only be more
accurate and reliable in predicting clinically relevant
hypocalcemia than serial Ca monitoring, it might also
eliminate the need for drawing blood multiple times and an
overnight stay.
In our analysis, test sensitivity and speciﬁcity of
PTH-SC were 82.4 and 95.0 %, respectively, and were
consistentwiththosereportedbyotherauthors[12,13,16].It
was interesting to note that the overall accuracy of PTH-D1
was lower than that of PTH-SC, despite the fact that it was
taken later or closer to the time of hospital discharge. It was
observedthatthe PTH-D1levels overallwerelowerthan the
PTH-SC levels in both groups I and II, suggesting that per-
haps postoperative PTH levels fell regardless of whether the
patient would eventually develop clinically relevant hypo-
calcemia or not. Unlike previous studies, our cutoff values
were calculated from the ROC and Youden’s index in order
to ﬁnd the best balance between test sensitivity and speci-
ﬁcity.Coincidentally,thesecutoffvaluesappearedsimilarto
those reported in previous studies [9, 13, 17, 18].
However, despite these encouraging results, PTH-SC was
not 100 % accurate. Most concerning was that 3/98 or 3.1 %
of patients with PTH-SC [1 pmol/L still required calcium
supplements on discharge. One patient had PTH-SC =
4.6 pmol/L and yet the adjusted Ca fell to 1.89 mmol/L on
the following morning after surgery. One could argue that
with time, this patient’s adjusted Ca might have spontane-
ously returned to above 1.90 pmol/L because this patient
never experienced any hypocalcemic symptoms and only
calcium 500 mg daily was prescribed on discharge. Never-
theless, if oral calcium and calcitriol requirements were
analyzed more closely, none of the three patients with PTH-
SC[1 pmol/L required both oral calcium and calcitriol on
discharge, suggesting that they suffered from only mild
hypocalcemia. In contrast, 6 of 14 patients with PTH-SC
B1 pmol/L required both oral calcium and calcitriol and 2
eventually developed permanent hypoparathyroidism.
Therefore, perhaps in the future, patients with PTH-SC
[1 pmol/L could be discharged on the same day of surgery
and be instructed to take oral calcium when hypocalcemic
symptoms develop as the chance of a life-threatening
World J Surg (2012) 36:1300–1306 1305
123episode of severe hypocalcemia would seem unlikely in this
group of patients. However, the group with PTH-SC
B1 pmol/L would need closer monitoring because even
though 5/19 or 26.3 % never developed clinically relevant
hypocalcemia, the other 14 required some oral calcium and/
or calcitriol supplements to maintain normocalcemia.
Perhaps, the safest strategy would be to keep this group of
patients overnight after surgery for serial Ca monitoring.
One point worth discussing is that although the quick PTH
assay used in the present study may cost more than the
conventional PTH assay, the former is able to produce the
PTH result more quickly and, in our opinion, this helps to
facilitate early hospital discharge and ambulatory surgery
and reduce the overall medical cost of the operation.
Conclusion
Preoperative Ca level and PTH-SC were the two most
signiﬁcant determinants of hypocalcemia after total or
completion thyroidectomy. PTH-SC was more sensitive,
speciﬁc, and predictive than the conventional overnight Ca
monitoring and PTH-D1. Given that only 3.1 % of patients
had mild hypocalcemia, it would seem a reasonable
approach to discharge patients with PTH-SC[1 pmol/L on
the same day of surgery as the risk of a life-threatening
hypocalcemic episode is unlikely. However, we would
recommend those with PTH-SC B1 pmol/L should have at
least one overnight hospital stay for Ca monitoring.
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